Pier Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-142,184
Closed -$3.41M 120
2019
Q3
$3.41M Buy
142,184
+62
+0% +$1.65K 0.58% 85
2019
Q2
$4.05M Sell
142,122
-63,098
-31% -$1.58M 0.63% 88
2019
Q1
$5.13M Sell
205,220
-166,829
-45% -$3.19M 0.8% 76
2018
Q4
$4.68M Sell
372,049
-269,808
-42% -$3.19M 0.93% 62
2018
Q3
$6.13M Buy
+641,857
New +$7.08M 0.77% 80
2014
Q3
Sell
-198,736
Closed -$3.4M 158
2014
Q2
$3.4M Buy
+198,736
New +$2.86M 0.48% 95

Other funds holding VCYT

Pier Capital's VCYT Position: Q4 2019 in Review

Pier Capital sold out of Veracyte (VCYT) in Q4 2019, closing a stake of 142,184 shares — an estimated $3.41M sold.

Pier Capital first reported a position in VCYT in Q2 2014 and held it in 6 quarters. The position peaked at $6.13M in Q3 2018. 179 funds tracked by Wall St. Rank hold VCYT as of Q4 2019.

  • Pier Capital reported no remaining Veracyte position as of Q4 2019 after selling out during the quarter.
  • Pier Capital sold 142,184 Veracyte shares in Q4 2019, an estimated $3.41M.
  • Pier Capital first reported a position in Veracyte in Q2 2014 and held it in 6 quarters.
  • Pier Capital's Veracyte position peaked at $6.13M in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Veracyte as of Q4 2019.

Based on Pier Capital's 13F filing for Q4 2019, filed 14 Feb 2020.